Those interested in a money-back guarantee
still appropriate for patients not on CGM, especially on insulin Inpatient Diabetes Management Per ADA 2026 Section 16 (Diabetes Care in the Hospital), insulin is the preferred agent for managing hyperglycemia in hospitalized patients (target BG 140180 mg/dL per ICU guidelines
Oral semaglutide, which has less systemic absorption than injectable formulations, may require shorter discontinuation periods, but this decision remains with your surgical team
Note, however, that some of these programs require that the individual not have other coverage for the drug
The PI3K/AKT pathway in obesity and type 2 diabetes
Popular GLP-1 medications like Semaglutide (Wegovy) and Tirzepatide (Mounjaro) have helped patients achieve significant weight loss when combined with lifestyle changes